Factors that predict development of chronic kidney disease in patients with rheumatoid arthritis receiving biologic DMARDs and mortality rates.

Güllü Sandal Uzun Arzu Taghiyeva Ibrahim Yahya Cakir Kenan Moral Gözde Kübra Yardimci Ertuğrul Çağri Bölek Bayram Farisoğulları Emine Duran Gizem Ayan Zehra Özsoy Mustafa Ekici Erdinç Unaldı Serife Asya Germe Busra Firlatan Gözde S Kart-Bayram Abdulsamet Erden Levent Kilic Ömer Karadağ Ali Akdoğan Şaziye Şule Apraş Bilgen Sedat Kiraz Ali Ihsan Ertenli Umut Kalyoncu

Published in: International journal of rheumatic diseases (2023)

Comorbidities and control of disease activity are critical in the development of CKD in RA patients receiving b/ts-DMARDs. While there was no significant difference in mortality rate between CKD and non-CKD patients, the overall mortality rate increased after the COVID-19 pandemic duration in both groups.

Keyphrases

chronic kidney disease
end stage renal disease
disease activity
rheumatoid arthritis
rheumatoid arthritis patients
cardiovascular events
systemic lupus erythematosus
ankylosing spondylitis
risk factors
newly diagnosed
juvenile idiopathic arthritis
ejection fraction
cardiovascular disease